BioAtla (BCAB) Enterprise Value (2020 - 2026)

BioAtla (BCAB) has reported Enterprise Value for 7 consecutive years, with $5.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value fell 99.53% year-over-year to $5.3 million; the trailing twelve-month figure through Jun 2026 stood at $5.3 million (down 99.53% YoY), and the FY2025 full-year result was $1.8 billion, up 7.55% from the prior year.
• Enterprise Value eased to $5.3 million in Q2 2026 per BCAB's latest filing, from $11.4 million in the prior quarter.
• Across five years, Enterprise Value topped out at $18.9 billion in Q4 2022 and bottomed at $5.3 million in Q2 2026.
• Historically, Enterprise Value has averaged $5.1 billion across 5 years, with a median of $4.1 billion in 2023.
• The sharpest annual moves came in 2023 and 2026: Enterprise Value jumped 42.12% in 2023, then tumbled 99.53% in 2026.
• Over 5 years, Enterprise Value stood at $18.9 billion in 2022, then sank by 69.3% to $5.8 billion in 2023, then plunged by 71.25% to $1.7 billion in 2024, then grew by 7.55% to $1.8 billion in 2025, then sank by 99.7% to $5.3 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $5.3 million, $11.4 million, and $1.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.